Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
1 hedge funds and large institutions have $27 invested in Silk Road Medical, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.
99% less funds holding
Funds holding: 172 → 1 (-171)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $1.03B → $27 (-$1.03B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 170
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$91.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$80.3M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$53.3M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$42.7M |
| 5 |
BAMCO Inc
New York
|
-$34.6M |
SILK Hedge Fund Activity: Q3 2024 in Review
1 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2024, worth a combined $27 — down 100% from $1.03B a quarter earlier.
Sellers outnumbered buyers: 170 funds closed out of SILK and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $91.1M sold.
- 1 institutional investor held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2024, down from 172 in Q2 2024.
- Funds reported $27 of Silk Road Medical, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2024 and 170 closed out, a net change of -170 holders.
- The largest Silk Road Medical, Inc. Common Stock seller in Q3 2024 was BlackRock, an estimated $91.1M sold.
Based on aggregated 13F filings for Q3 2024.